Genmab

Genmab is a Danish listed biotech company specialising in differentiated human antibody therapeutics for the treatment of cancer.

  • Kempen & Co acted as placement agent in Genmab’s 2015 cashless warrant exercise 
Disclaimer Kempen & Co Privacy statement Asset Management Privacy statement Merchant Banking Statement under the UK Modern Slavery Act Cookie Settings
Kempen & Co NV is part of Van Lanschot Kempen Van Lanschot